de Vries IJM - Search Results

1

Exploring immune status in peripheral blood and tumor tissue in association with survival in patients with multi-organ metastatic colorectal cancer.

Bakkerus L, Subtil B, Bontkes HJ, Gootjes EC, Reijm M, Vullings M, Verrijp K, Bokhorst JM, Woortman C, Nagtegaal ID, Jonker MA, van der Vliet HJ, Verhoef C, Gorris MAJ, de Vries IJM, de Gruijl TD, Verheul HMW, Buffart TE, Tauriello DVF. Bakkerus L, et al. Among authors: de vries ijm. Oncoimmunology. 2024 Jun 10;13(1):2361971. doi: 10.1080/2162402X.2024.2361971. eCollection 2024. Oncoimmunology. 2024. PMID: 38868078 Free PMC article.

2

Insight into the dynamics, localization and magnitude of antigen-specific immune responses by [(18)F]FLT PET imaging.

Aarntzen EH, Srinivas M, Punt CJ, Figdor CG, Oyen WJ, de Vries IJ. Aarntzen EH, et al. Oncoimmunology. 2012 Aug 1;1(5):744-745. doi: 10.4161/onci.19533. Oncoimmunology. 2012. PMID: 22934268 Free PMC article.

3

Naturally circulating dendritic cells to vaccinate cancer patients.

Bol KF, Tel J, de Vries IJ, Figdor CG. Bol KF, et al. Oncoimmunology. 2013 Mar 1;2(3):e23431. doi: 10.4161/onci.23431. Oncoimmunology. 2013. PMID: 23802086 Free PMC article.

4

Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients.

Bol KF, Mensink HW, Aarntzen EH, Schreibelt G, Keunen JE, Coulie PG, de Klein A, Punt CJ, Paridaens D, Figdor CG, de Vries IJ. Bol KF, et al. Am J Ophthalmol. 2014 Nov;158(5):939-47. doi: 10.1016/j.ajo.2014.07.014. Epub 2014 Jul 17. Am J Ophthalmol. 2014. PMID: 25038326 Free article. Clinical Trial.

5

Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination.

Bol KF, Aarntzen EH, Hout FE, Schreibelt G, Creemers JH, Lesterhuis WJ, Gerritsen WR, Grunhagen DJ, Verhoef C, Punt CJ, Bonenkamp JJ, de Wilt JH, Figdor CG, de Vries IJ. Bol KF, et al. Oncoimmunology. 2015 Jun 5;5(1):e1057673. doi: 10.1080/2162402X.2015.1057673. eCollection 2016. Oncoimmunology. 2015. PMID: 26942068 Free PMC article.

6

T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines.

Vasaturo A, Halilovic A, Bol KF, Verweij DI, Blokx WA, Punt CJ, Groenen PJ, van Krieken JH, Textor J, de Vries IJ, Figdor CG. Vasaturo A, et al. Cancer Res. 2016 Jun 15;76(12):3496-506. doi: 10.1158/0008-5472.CAN-15-3211. Epub 2016 Apr 11. Cancer Res. 2016. PMID: 27197179

7

Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.

Bakdash G, Buschow SI, Gorris MA, Halilovic A, Hato SV, Sköld AE, Schreibelt G, Sittig SP, Torensma R, Duiveman-de Boer T, Schröder C, Smits EL, Figdor CG, de Vries IJ. Bakdash G, et al. Cancer Res. 2016 Aug 1;76(15):4332-46. doi: 10.1158/0008-5472.CAN-15-1695. Epub 2016 Jun 20. Cancer Res. 2016. PMID: 27325645

8

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients.

Boudewijns S, Bol KF, Schreibelt G, Westdorp H, Textor JC, van Rossum MM, Scharenborg NM, de Boer AJ, van de Rakt MW, Pots JM, van Oorschot TG, Duiveman-de Boer T, Olde Nordkamp MA, van Meeteren WS, van der Graaf WT, Bonenkamp JJ, de Wilt JH, Aarntzen EH, Punt CJ, Gerritsen WR, Figdor CG, de Vries IJ. Boudewijns S, et al. Oncoimmunology. 2016 May 31;5(7):e1191732. doi: 10.1080/2162402X.2016.1191732. eCollection 2016 Jul. Oncoimmunology. 2016. PMID: 27622047 Free PMC article.

9

Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death.

Di Blasio S, Wortel IM, van Bladel DA, de Vries LE, Duiveman-de Boer T, Worah K, de Haas N, Buschow SI, de Vries IJ, Figdor CG, Hato SV. Di Blasio S, et al. Oncoimmunology. 2016 Aug 3;5(8):e1192739. doi: 10.1080/2162402X.2016.1192739. eCollection 2016 Aug. Oncoimmunology. 2016. PMID: 27622063 Free PMC article.

10

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination.

Boudewijns S, Koornstra RH, Westdorp H, Schreibelt G, van den Eertwegh AJ, Geukes Foppen MH, Haanen JB, de Vries IJ, Figdor CG, Bol KF, Gerritsen WR. Boudewijns S, et al. Oncoimmunology. 2016 Jun 17;5(8):e1201625. doi: 10.1080/2162402X.2016.1201625. eCollection 2016 Aug. Oncoimmunology. 2016. PMID: 27622070 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters